The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has announced its four new strategic priorities, and has appointed steering committees to lead collaboration in these areas: Harness AI to Expedite R&D, Deliver Data-Driven Value, Sustainability Driven R&D and Accelerate Use of Real-World Data. The priorities were selected in response to the evolving needs of the life science industry amid digital transformation, climate change, and shifts in how research is conducted and healthcare is delivered...
Four trusts in the Greater Manchester Pathology Network are working to deploy Clinisys’ laboratory information management system (LIMS) in a way that will enable them to work more collaboratively and improve services for clinicians and patients. In a series of tenders, Tameside, Stockport, Bolton, and Northern Care Alliance (NCA) NHS Trusts have all awarded Clinisys for their WinPath LIMS, and plans are now being developed to interface the systems to create an “integrated, interoperable LIMS service” across the network...
Eremid® Genomic Services, LLC (“Eremid”) announces a strategic partnership with Semaphore Solutions, a leader in informatics services and SaaS solutions for the life sciences industry. Eremid will implement Semaphore’s Labbit LIMS across its research, clinical, and training labs, a move that will advance its laboratory operations in customized contract research...
Agilent Technologies Inc. has announced that Jennifer Field, an influential researcher in environmental analysis, has been selected to receive a prestigious Agilent Thought Leader Award. A professor in the Environmental and Molecular Toxicology Department at Oregon State University’s College of Agricultural Sciences, Dr. Field focuses her research on the quantitative analysis of organic micropollutants and their transformation products in natural and engineered systems, particularly per- and polyfluoroalkyl substances (PFAS)...
The UK’s largest trade show for the entire laboratory industry, Lab Innovations, returned to the NEC, Birmingham, earlier this month to champion sustainability and innovation in the lab industry. This year’s show saw record-breaking numbers across the board, with more exhibitors, speakers and visitors than ever at Lab Innovations 2023. 4,362 visitors attended the show across two days to network and do business with 202 exhibitors, 80% per cent of which have already rebooked for next year...
New Consortium Aims to Share Best Practices and Increase our Understanding of Genetic Disease. PacBio, a leading developer of high-quality, highly accurate sequencing solutions, has announced the creation of the HiFi Solves consortium. This global consortium brings together researchers from 15 leading genomics research institutions across 11 countries to study the value HiFi-based human genome sequencing may have in clinical research applications and to further our understanding of genetic diseases...
A start-up is developing technology to build a pharmaceuticals factory in space that could help improve the lives of patients undergoing antibody treatments for cancer and other diseases. Currently, for patients undergoing antibody cancer treatments, this involves spending hours at a time in hospital to undergo intravenous infusions, which are both time consuming and invasive. To address this issue, start-up company...
The Lab Awards, the leading awards ceremony for the UK’s laboratory industry, was held at The Vox, Birmingham, on November 1 and celebrated the lab industry’s key achievements from the past year. The event, brought to you by Lab Innovations and Laboratory News, crowned winners across fourteen categories, including Best Technology Innovation, Lab Technician of the Year and Sustainable Lab of the Year...
Leading integrated drug discovery, development and manufacturing organisation, Concept Life Sciences has carved out its Bradford analytical chemistry business to Cormica the specialists in testing services for medical device and pharmaceutical manufacturers. Both Concept Life Sciences and Cormica are part of private equity house, Limerston Capital LLP and sit as part of its healthcare portfolio...
Cresset, an innovative provider of solutions for computer-aided drug design (CADD), design-make-test-analyze (DMTA) efficiency, and drug discovery contract research has been accepted onto the Innovate UK Scaleup Programme, which aims to help specially selected businesses with scaling potential realise their commercial ambitions. From its headquarters in Cambridge, UK, Cresset has ambitious plans to scale up its international operations, building on its existing commercial presence in North America and Asia...
The Institute of Cancer Research, London, and science and technology company Merck have renewed their strategic alliance in the discovery and development of new cancer drugs. Scientists in the Centre for Cancer Drug Discovery at The Institute of Cancer Research (ICR) will work with researchers at Merck on a range of related projects, each of which aim to discover and develop new small-molecule inhibitors of an exciting new class of cancer targets...
OGT, a Sysmex Group Company and leading global provider of genomic research and diagnostic solutions, is delighted to announce its new partnership with Intelliseq, a genome informatics company and innovative provider of Next-Generation Sequencing (NGS) analysis solutions. This collaboration combines OGT's expansive SureSeq™ NGS portfolio with Intelliseq's state-of-the-art iFlow™ engine, resulting in a thorough and comprehensive NGS workflow—from sample to report...
Biotech company, Cytomos is pleased to announce that it has been selected to showcase its dielectric spectroscopy (CDS) platform at the BIA’s BioProcess UK Dragon’s Den special session focused on next generation analytical technologies, taking place on day two of this year’s annual conference: 30 November. Cytomos’ CSO, Dr. Lindsay Fraser, will highlight the benefits and full potential of Cytomos’ transformative CDS technology and take questions from inquisitive delegates...
A new development in Cell Line Engineering technology is set to cut drug development times by up to 12 months, allowing greater reinvestment in lifesaving medicines, and a quicker path to market. Promega, the company behind the breakthrough, has developed ready-to-use CRISPR-generated Knock-In Reporter Cell Lines that contain a proprietary, small bioluminescent tag. Not only will this discovery accelerate products to market, but it can save biotech companies up to £6 million in the drug development process...
Global sustainable laboratory equipment visionaries, Asynt, have collaborated with Kingston University (London, UK) and renowned worldwide chemical products supplier, Key Organics, to develop an accessible new synthetic compound library. Chemists from the Wren Group at Kingston University (UK) have formed a collaborative relationship with these industry leaders, enabling them to create a novel synthetic compound library....
Nikon Instruments Inc. has unveiled the winners of the 49th annual Nikon Small World Photomicrography Competition. This year’s first place prize was awarded to Hassanain Qambari, assisted by Jayden Dickson of the Lions Eye Institute, for his vivid image of a rodent optic nerve head showing astrocytes (yellow), contractile proteins (red), and retinal vasculature (green). The colorful image provides an important contribution to the study and reversal of diabetic retinopathy, which affects one in five persons with diabetes worldwide...
Revvity, Inc. announces a value-added distribution agreement with SCIEX, a global leader in life science analytical technologies. This strategic agreement is aimed at advancing mass spectrometry solutions in Revvity's newborn screening products and the anticipated solution combines Revvity’s expertise and resources with SCIEX’s innovative mass spectrometry solutions. With this agreement, Revvity hopes to further help laboratories identify newborn babies with a range of rare disorders...
The life science group Sartorius and UK-based startup SPARTA Biodiscovery have agreed to partner on SPARTA’s analysis platform, which helps speed up the development, manufacture, and quality control of nanoparticles for biopharmaceutical drugs. Nanoparticles are small polymer or lipid capsules that act as carriers to deliver active agents to the target cells. As part of the cooperation, Sartorius will invest up to 3.5 million British pounds in a minority shareholding in SPARTA Biodiscovery through its corporate investment unit Sartorius Ventures...
A new research announcement to leverage the unique environment of the International Space Station (ISS) to advance tissue engineering and biomanufacturing is now open. The ISS National Laboratory® is soliciting concepts for applied research and technology development for regenerative medicine applications seeking to demonstrate space-based manufacturing and production activities for terrestrial applications...
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, and 10x Genomics, Inc., a leader in single cell and spatial biology, today announced a new partnership to expand automation solutions for single cell assay workflows. As part of the agreement, 10x Genomics plans to develop dedicated Chromium Single Cell kits to be used on a Biomek i7 Automated Liquid Handler by Beckman Coulter Life Sciences...
Innovator in laboratory digital transformation and leading global provider of cloud-based solutions for science, Scitara, presents its Digital Lab Exchange DLX™ platform as the missing link that enables laboratories to embrace true digital transformation and develop a modern composable enterprise-led IT strategy at Lab of the Future Europe 2023. Composable enterprise, a term coined by Gartner, is now the standard in IT development to help teams work faster and more efficiently...
EVONETIX LTD, the Company developing semiconductor scale technology to improve access to gene synthesis, has announced its first placement of a DNA synthesis development platform for evaluation at Imperial College London. This is the Company’s first platform to be installed in an external scientific setting; a significant milestone as it continues to optimize its gene synthesis technology in preparation for customer use and commercialization...